RO7239361
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO7239361, covering 2019-05-08 to 2020-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy [Phase 2, Phase 3]